NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Net other income and expenses outside core operations

Percentile
P100
Near historical high
vs 2Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$21.86M+133.5%
2024$-65.31M-1178.3%
2023$6.06M+131.8%
2022$-19.08M-180.2%
2021$-6.81M-1641.6%
2020$-390912.00-